ART4
gene geneOn this page
Also known as DOK1CD297ARTC4
Summary
ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group), HGNC:726) is a protein-coding gene on chromosome 12p12.3, encoding Ecto-ADP-ribosyltransferase 4 (Q93070).
This gene encodes a protein that contains a mono-ADP-ribosylation (ART) motif. It is a member of the ADP-ribosyltransferase gene family but enzymatic activity has not been demonstrated experimentally. Antigens of the Dombrock blood group system are located on the gene product, which is glycosylphosphatidylinosotol-anchored to the erythrocyte membrane. Allelic variants, some of which lead to adverse transfusion reactions, are known.
Source: NCBI Gene 420 — RefSeq curated summary.
At a glance
- Gene–disease (curated): age related macular degeneration 8 (Moderate, GenCC)
- GWAS associations: 1
- Clinical variants (ClinVar): 46 total
- GTEx eGene: eQTL in 7 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.01 (LoF-tolerant), LOEUF 0.90 (unconstrained)
- MANE Select transcript:
NM_021071
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:726 |
| Approved symbol | ART4 |
| Name | ADP-ribosyltransferase 4 (inactive) (Dombrock blood group) |
| Location | 12p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DOK1, CD297, ARTC4 |
| Ensembl gene | ENSG00000111339 |
| Ensembl biotype | protein_coding |
| OMIM | 110600 |
| Entrez | 420 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
MANE Select: ENST00000228936
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 4
ENST00000228936, ENST00000420600, ENST00000430129, ENST00000544616, ENST00001110940, ENST00001134633
RefSeq mRNA: 2 — MANE Select: NM_021071
NM_001354646, NM_021071
CCDS: CCDS8668
Canonical transcript exons
ENST00000228936 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000723031 | 14840445 | 14841153 |
| ENSE00000915534 | 14842970 | 14843526 |
| ENSE00001603649 | 14825569 | 14829462 |
Expression profiles
Bgee: expression breadth ubiquitous, 161 present calls, max score 84.96.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8424 / max 192.7353, expressed in 332 samples.
Highest expression (Bgee): liver, lobe of liver, coronary artery, atrium auricular region, thoracic aorta.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ART4 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
7 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Artery Tibial | eqtl | 2.8e-04 | -0.14 | 12:14894462:T:C |
| Heart Atrial Appendage | eqtl | 1.6e-03 | +0.18 | 12:14917701:C:G |
| Thyroid | eqtl | 3.1e-03 | +0.17 | 12:14832270:C:T |
| Colon Transverse | eqtl | 7.4e-03 | +0.39 | 12:15679206:A:G |
| Artery Aorta | eqtl | 1.7e-02 | -0.14 | 12:14892493:T:C |
| Pituitary | eqtl | 2.1e-02 | +1.15 | 12:14314855:G:A |
| Spleen | eqtl | 2.9e-02 | +0.21 | 12:15077865:G:C |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 129856 | 1.1344 | 305 |
| 129857 | 0.6288 | 214 |
| 129858 | 0.0792 | 34 |
Top tissues by expression
showing 100 of 286 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| liver | UBERON:0002107 | 84.96 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.38 | gold quality |
| right coronary artery | UBERON:0001625 | 82.75 | gold quality |
| right atrium auricular region | UBERON:0006631 | 80.73 | gold quality |
| thoracic aorta | UBERON:0001515 | 80.49 | gold quality |
| ascending aorta | UBERON:0001496 | 80.28 | gold quality |
| gall bladder | UBERON:0002110 | 80.23 | gold quality |
| cardiac atrium | UBERON:0002081 | 79.95 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 79.18 | gold quality |
| left coronary artery | UBERON:0001626 | 78.78 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 78.69 | gold quality |
| spleen | UBERON:0002106 | 78.10 | gold quality |
| lymph node | UBERON:0000029 | 78.00 | gold quality |
| coronary artery | UBERON:0001621 | 77.83 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.08 | gold quality |
| aorta | UBERON:0000947 | 76.35 | gold quality |
| diaphragm | UBERON:0001103 | 75.39 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 73.90 | silver quality |
| popliteal artery | UBERON:0002250 | 73.53 | gold quality |
| tibial artery | UBERON:0007610 | 73.53 | gold quality |
| saphenous vein | UBERON:0007318 | 72.38 | gold quality |
| heart | UBERON:0000948 | 72.18 | gold quality |
| bone marrow | UBERON:0002371 | 71.87 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 70.68 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 70.39 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 70.10 | gold quality |
| thyroid gland | UBERON:0002046 | 69.87 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.86 | gold quality |
| apex of heart | UBERON:0002098 | 68.65 | gold quality |
| omental fat pad | UBERON:0010414 | 68.25 | gold quality |
| peritoneum | UBERON:0002358 | 68.17 | gold quality |
| heart left ventricle | UBERON:0002084 | 67.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 67.91 | gold quality |
| bone marrow cell | CL:0002092 | 67.76 | gold quality |
| cardiac ventricle | UBERON:0002082 | 67.56 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 66.86 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 66.74 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.55 | gold quality |
| adrenal gland | UBERON:0002369 | 66.04 | gold quality |
| adrenal cortex | UBERON:0001235 | 65.67 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 65.03 | gold quality |
| upper lobe of lung | UBERON:0008948 | 64.81 | gold quality |
| body of pancreas | UBERON:0001150 | 64.57 | gold quality |
| right lung | UBERON:0002167 | 64.38 | gold quality |
| left uterine tube | UBERON:0001303 | 63.67 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 63.56 | silver quality |
| lower lobe of lung | UBERON:0008949 | 63.44 | gold quality |
| pancreas | UBERON:0001264 | 63.04 | gold quality |
| vena cava | UBERON:0004087 | 62.23 | silver quality |
| lung | UBERON:0002048 | 61.99 | gold quality |
| placenta | UBERON:0001987 | 61.94 | gold quality |
| visceral pleura | UBERON:0002401 | 61.30 | gold quality |
| amniotic fluid | UBERON:0000173 | 61.29 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 60.85 | gold quality |
| superficial temporal artery | UBERON:0001614 | 60.71 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 60.70 | gold quality |
| vermiform appendix | UBERON:0001154 | 59.75 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 59.75 | gold quality |
| islet of Langerhans | UBERON:0000006 | 59.29 | gold quality |
| adipose tissue | UBERON:0001013 | 58.33 | gold quality |
| connective tissue | UBERON:0002384 | 58.24 | gold quality |
| adrenal tissue | UBERON:0018303 | 58.04 | gold quality |
| caecum | UBERON:0001153 | 57.91 | gold quality |
| endothelial cell | CL:0000115 | 57.61 | gold quality |
| kidney | UBERON:0002113 | 57.25 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.92 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 56.47 | gold quality |
| muscle tissue | UBERON:0002385 | 56.13 | gold quality |
| hair follicle | UBERON:0002073 | 56.00 | gold quality |
| pancreatic ductal cell | CL:0002079 | 55.82 | silver quality |
| rectum | UBERON:0001052 | 55.56 | gold quality |
| body of uterus | UBERON:0009853 | 55.54 | gold quality |
| myometrium | UBERON:0001296 | 54.94 | gold quality |
| cortex of kidney | UBERON:0001225 | 54.90 | gold quality |
| pleura | UBERON:0000977 | 54.84 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 54.63 | gold quality |
| lower esophagus | UBERON:0013473 | 54.52 | gold quality |
| metanephros | UBERON:0000081 | 54.51 | gold quality |
| heart right ventricle | UBERON:0002080 | 54.40 | silver quality |
| ectocervix | UBERON:0012249 | 54.23 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 54.06 | gold quality |
| endometrium epithelium | UBERON:0004811 | 53.93 | gold quality |
| endocervix | UBERON:0000458 | 53.88 | gold quality |
| cerebellar vermis | UBERON:0004720 | 53.78 | gold quality |
| fallopian tube | UBERON:0003889 | 53.70 | gold quality |
| tonsil | UBERON:0002372 | 53.57 | gold quality |
| deltoid | UBERON:0001476 | 53.42 | gold quality |
| skin of hip | UBERON:0001554 | 52.33 | gold quality |
| uterine cervix | UBERON:0000002 | 52.26 | gold quality |
| quadriceps femoris | UBERON:0001377 | 52.19 | gold quality |
| gastrocnemius | UBERON:0001388 | 52.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 52.07 | gold quality |
| muscle of leg | UBERON:0001383 | 52.00 | gold quality |
| muscle organ | UBERON:0001630 | 51.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 51.86 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 51.84 | silver quality |
| metanephric glomerulus | UBERON:0004736 | 51.83 | gold quality |
| kidney epithelium | UBERON:0004819 | 51.75 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 51.62 | gold quality |
| right ovary | UBERON:0002118 | 51.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.07 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 73 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Liver | tissue | 49.7 |
| Spleen | tissue | 17.9 |
| Cerebellum | tissue | 9.4 |
| Olfactory bulb | tissue | 9.3 |
| Gallbladder | tissue | 8.4 |
| Lymph node | tissue | 8.0 |
| Amygdala | tissue | 8.0 |
| Cerebral cortex | tissue | 7.7 |
| Insular cortex | tissue | 7.7 |
| Retrosplenial and cingulate cortex | tissue | 7.6 |
| Retrosplenial cortex | tissue | 7.5 |
| Temporal cortex | tissue | 7.4 |
| Corpus callosum | tissue | 7.3 |
| Hippocampal formation | tissue | 6.9 |
| Entorhinal cortex | tissue | 6.9 |
| Basal ganglia | tissue | 6.7 |
| Prefrontal cortex | tissue | 6.6 |
| Placenta | tissue | 6.5 |
| Ventral forebrain | tissue | 6.3 |
| Somatosensory cortex | tissue | 6.1 |
| Motor cortex | tissue | 5.9 |
| Occipital cortex | tissue | 5.9 |
| Putamen | tissue | 5.8 |
| Periaqueductal gray | tissue | 5.8 |
| Septum | tissue | 5.7 |
| Heart muscle | tissue | 5.6 |
| Hypothalamus | tissue | 5.1 |
| Midbrain | tissue | 4.7 |
| Spinal cord | tissue | 4.7 |
| Substantia nigra | tissue | 4.6 |
| Medulla oblongata | tissue | 4.4 |
| Bone marrow | tissue | 4.3 |
| Thalamus | tissue | 4.0 |
| Superior colliculi | tissue | 4.0 |
| Pons | tissue | 3.5 |
| Kidney | tissue | 3.4 |
| Lung | tissue | 3.0 |
| Thyroid gland | tissue | 2.8 |
| Adrenal gland | tissue | 2.6 |
| Tonsil | tissue | 2.2 |
| Adipose tissue | tissue | 2.1 |
| Pancreas | tissue | 2.1 |
| Choroid plexus | tissue | 2.0 |
| Locus coeruleus | tissue | 2.0 |
| Fallopian tube | tissue | 1.9 |
| Thymus | tissue | 1.8 |
| Breast | tissue | 1.7 |
| Nucleus accumbens | tissue | 1.7 |
| Postcentral gyrus | tissue | 1.7 |
| Hippocampus | tissue | 1.5 |
| Smooth muscle | tissue | 1.0 |
| Appendix | tissue | 1.0 |
| Cervix | tissue | 0.9 |
| Esophagus | tissue | 0.8 |
| Ovary | tissue | 0.7 |
| Salivary gland | tissue | 0.6 |
| Colon | tissue | 0.6 |
| Urinary bladder | tissue | 0.6 |
| Vagina | tissue | 0.5 |
| Rectum | tissue | 0.5 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Blood vessel (9.2), White matter (7.3), Subiculum (6.4), Ventral hippocampus (6.2), Dorsal hippocampus (5.2).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 0.00999, LOEUF 0.895, missense Z 0.444 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000228936 — one region, missense o/e 0.97.
Literature-anchored findings (GeneRIF, showing 7)
- Expression of ART4 was analyzed in mononuclear leukocytes. (PMID:16140404)
- Dombrock genotyping in a native Congolese cohort reveals two novel alleles. (PMID:19413734)
- The Dombrock blood group system (PMID:20932078)
- The production, serologic evaluation, and epitope mapping of ten murine monoclonal Dombrock antibodies. (PMID:23421541)
- Characterization of two novel DO*B alleles highlights the value of testing selected ethnic groups in understanding DO allele diversity. (PMID:25988428)
- A novel variant DO*A allele with a c.370delT mutation leading to a DO-null phenotype in a Syrian family. (PMID:33206405)
- Development of DO*A and DO*B Allele Detections to Predict Transfusion-Induced Alloimmunization Risks in Thai Populations. (PMID:34655192)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-145b13.6 | ENSDARG00000069998 |
| mus_musculus | Art4 | ENSMUSG00000030217 |
| rattus_norvegicus | Art4 | ENSRNOG00000005670 |
Paralogs (3): ART1 (ENSG00000129744), ART3 (ENSG00000156219), ART5 (ENSG00000167311)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1202710) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| increased red blood cell distribution width | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pan troglodytes | Q95NE0 | 99.4% | Diamond |
| Oryctolagus cuniculus | Q03515 | 81.3% | Diamond |
| Gallus gallus | P55806 | 81.1% | Diamond |
| Bos taurus | Q0VC22 | 67.9% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| ERP27 | protein-coding | 121506 |
| ARHGDIB | protein-coding | 397 |
| MGP | protein-coding | 4256 |
| C12orf60 | protein-coding | 144608 |
| SMCO3 | protein-coding | 440087 |
| WBP11 | protein-coding | 51729 |
| H2AJ | protein-coding | 55766 |
| H4C16 | protein-coding | 121504 |
Protein
Protein identifiers
Ecto-ADP-ribosyltransferase 4 — Q93070 (reviewed: Q93070)
Alternative names: ADP-ribosyltransferase C2 and C3 toxin-like 4, Dombrock blood group carrier molecule, Mono(ADP-ribosyl)transferase 4, NAD(P)(+)–arginine ADP-ribosyltransferase 4
All UniProt accessions (4): H7C2G2, Q3KZ29, Q3KZ30, Q93070
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane.
Tissue specificity. Expressed in spleen and T-cells.
Polymorphism. Variations in the ART4 gene are the basis of the Dombrock blood group system (Do). ART4 carries two antithetical antigens (Do(a) and Do(b)) and 3 high-incidence antigens, Gregory (Gy(a)), Holley (Hy), and Joseph (Jo(a)). Do(a) and Do(b) differ by a single variation at position 265, with Asn-265 corresponding to Do(a) and Asp-265 (shown in this entry) to Do(b).
Similarity. Belongs to the Arg-specific ADP-ribosyltransferase family.
RefSeq proteins (2): NP_001341575, NP_066549* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000768 | ART | Family |
| IPR050999 | ADP-ribosyltransferase_ARG | Family |
Pfam: PF01129
Catalyzed reactions (Rhea)
- L-arginyl-[protein] + NAD(+) = N(omega)-(ADP-D-ribosyl)-L-arginyl-[protein] + nicotinamide + H(+) (RHEA:19149)
UniProt features (23 total): sequence variant 6, glycosylation site 5, binding site 3, disulfide bond 2, sequence conflict 2, signal peptide 1, chain 1, propeptide 1, domain 1, lipid moiety-binding region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q93070-F1 | 81.00 | 0.57 |
Human Protein Atlas
Protein class: Enzymes, ENZYME proteins, Transferases, Metabolic proteins, CD markers, Blood group antigen proteins, Predicted membrane proteins, Predicted secreted proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): rods & rings
Antibody reliability (HPA): IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3)
| Position | Role |
|---|---|
| 126 | NAD(+) |
| 206 | NAD(+) |
| 240 | NAD(+) |
Post-translational modifications (1)
| Type | Positions |
|---|---|
| Gpi-anchor amidated alanine | 285 |
Disulfide bonds (2)
| Type | Positions |
|---|---|
| Disulfide bond | 69–280, 182–231 |
Glycosylation sites (5)
| Type | Positions |
|---|---|
| N-linked (glcnac…) asparagine | 222, 257, 274, 114, 178 |
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 3; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
3 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins | curated |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-597592 | Post-translational protein modification | — |
MSigDB gene sets: 329 (showing top):
PID_BCR_5PATHWAY, GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, MORF_RAGE, GGGACCA_MIR133A_MIR133B, DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, GOBP_RESPONSE_TO_PEPTIDE, GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS, MODULE_45, MORF_ATRX, RIZKI_TUMOR_INVASIVENESS_3D_DN, MORF_ESR1, MODULE_16, BROWNE_HCMV_INFECTION_48HR_DN, MODULE_120
GO Biological Process (1): arginine metabolic process (GO:0006525)
GO Molecular Function (5): NAD+ poly-ADP-ribosyltransferase activity (GO:0003950), nucleotidyltransferase activity (GO:0016779), NAD+-protein-arginine ADP-ribosyltransferase activity (GO:0106274), transferase activity (GO:0016740), glycosyltransferase activity (GO:0016757)
GO Cellular Component (3): extracellular region (GO:0005576), plasma membrane (GO:0005886), side of membrane (GO:0098552)
Reactome top-level categories
2 top-level categories:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
11 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| membrane | 2 |
| amino acid metabolic process | 1 |
| carboxylic acid metabolic process | 1 |
| pentosyltransferase activity | 1 |
| transferase activity, transferring phosphorus-containing groups | 1 |
| NAD+-protein mono-ADP-ribosyltransferase activity | 1 |
| catalytic activity | 1 |
| transferase activity | 1 |
| cell periphery | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
showing 15 of 192 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ART4 | PCYOX1 | Q9UHG3 | 473 |
| ART4 | PARP15 | Q460N3 | 407 |
| ART4 | ART3 | Q13508 | 382 |
| ART4 | PARP12 | Q9H0J9 | 379 |
| ART4 | SMCO3 | A2RU48 | 355 |
| ART4 | PARP8 | Q8N3A8 | 349 |
| ART4 | PARP14 | Q460N5 | 337 |
| ART4 | PARP16 | Q8N5Y8 | 315 |
| ART4 | HPF1 | Q9NWY4 | 309 |
| ART4 | PCYOX1L | Q8NBM8 | 294 |
| ART4 | ZC3HAV1 | Q7Z2W4 | 286 |
| ART4 | PARP4 | Q9UKK3 | 270 |
| ART4 | GDAP2 | Q9NXN4 | 260 |
| ART4 | SPAG16 | Q8N0X2 | 254 |
| ART4 | TYROBP | O43914 | 252 |
IntAct
Human interaction partners of ART4 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
1 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| GPAA1 | association | 0.350 | 1 |
BioGRID (18 interactions; top human partners by supporting records): AMBRA1 (Affinity Capture-MS), APP (Reconstituted Complex), CANX (Affinity Capture-MS), GPAA1 (Affinity Capture-MS), GPM6A (Affinity Capture-MS), LINC00667 (Protein-RNA), MYC (Proximity Label-MS), PARP12 (Proximity Label-MS), PIGS (Affinity Capture-MS), PIGU (Affinity Capture-MS), PKD2 (Affinity Capture-MS), PSMD14 (Affinity Capture-MS), PTEN (Affinity Capture-MS), TMX1 (Affinity Capture-MS), TRIM21 (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for ART4: 46 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 2 |
| Benign | 3 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 19 predictions of 122):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 12:14841154–14841155 | acceptor_loss | 0.9900 | 6 |
| 12:14842968–14842969 | donor_loss | 0.9900 | 5 |
| 12:14842968 | donor_loss | 0.9600 | |
| 12:14840568 | donor_gain | 0.9500 | |
| 12:14839291 | donor_gain | 0.9300 | |
| 12:14841156 | acceptor_loss | 0.9200 | |
| 12:14843050 | donor_gain | 0.8900 | |
| 12:14840493 | donor_gain | 0.8000 | |
| 12:14842970 | donor_loss | 0.7900 | |
| 12:14843469 | donor_gain | 0.7700 |
AlphaMissense
235 missense substitutions predicted likely pathogenic (of 2,070 scored), across 75 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D64 | 8 | 0.803 | 0.867 |
| F253 | 7 | 0.915 | 0.946 |
| F207 | 7 | 0.875 | 0.964 |
| C280 | 7 | 0.829 | 0.914 |
| F154 | 7 | 0.822 | 0.955 |
| W97 | 7 | 0.790 | 0.915 |
| C69 | 7 | 0.787 | 0.878 |
| C231 | 7 | 0.781 | 0.840 |
| C182 | 7 | 0.765 | 0.849 |
| D63 | 7 | 0.748 | 0.818 |
| F156 | 7 | 0.733 | 0.913 |
| E251 | 6 | 0.855 | 0.927 |
| F204 | 6 | 0.794 | 0.909 |
| Y66 | 5 | 0.883 | 0.916 |
| S276 | 5 | 0.865 | 0.925 |
| F62 | 5 | 0.859 | 0.940 |
| K157 | 5 | 0.814 | 0.901 |
| H160 | 5 | 0.732 | 0.835 |
| F136 | 5 | 0.676 | 0.779 |
| Y161 | 4 | 0.787 | 0.919 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Liver Hepatocellular Carcinoma)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Breast Invasive Carcinoma (validation) | favorable | 0.000148 |
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 0.000763 |
Disease associations
OMIM: gene MIM:110600 | disease phenotypes:
GenCC curated gene-disease
1 curated gene-disease records:
| Disease | Classification | Inheritance | Records |
|---|---|---|---|
| age related macular degeneration 8 | Moderate | Autosomal recessive |
Mondo (1): age related macular degeneration 8 (MONDO:0013416)
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST005830_56 | Hand grip strength | 1e-12 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0006941 | grip strength measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression | 3 |
| Acetaminophen | decreases expression | 2 |
| Benzo(a)pyrene | decreases expression | 2 |
| Estradiol | decreases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression, decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| propionaldehyde | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| bisphenol A | affects expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ferrous chloride | increases expression | 1 |
| epigallocatechin gallate | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| bisphenol S | decreases expression | 1 |
| Acetylcysteine | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cytarabine | decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Sodium Selenite | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E8VR | Jurkat-hART4 | Cancer cell line | Male |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: age related macular degeneration 8
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): age related macular degeneration 8